This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a colleague Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Hickey, R. Articles by Winnie, A. P. Search for Related Content PubMed PubMed Citation Articles by Hickey, R. Articles by Winnie, A. P.

A Comparative Study of 0.25% Ropivacaine and 0.25% Bupivacaine for Brachial Plexus Block

Departments of Anesthesiology, University of Texas Health Science Center at San Antonio, San Antonio, Texas, and University of Illinois College of Medicine at Chicago, Chicago, Illinois

The present study compares the effectiveness of 0.25% ropivacaine and 0.25% bupivacaine in 44 patients receiving a subclavian perivascular brachial plexus block for upper extremity surgery. The patients were assigned to two equal groups in this randomized, double-blind study; one group received ropivacaine 0.25% (112.5 mg) and the other, bupivacaine 0.25% (112.5 mg), both without epinephrine. Onset times for analgesia and anesthesia in each of the C-5 through T-1 brachial plexus dermatomes did not differ significantly between the two groups. The mean onset time for analgesia ranged from 11.2 to 20.2 min, and the mean onset time for anesthesia ranged from 23.3 to 48.2 min. The onset of motor block differed only with respect to paresis in the hand, with bupivacaine demonstrating a shorter onset time than ropivacaine. The duration of sensory and motor block also was not significantly different between the two groups. The mean duration of analgesia ranged from 9.2 to 13.0 h, and the mean duration of anesthesia ranged from 5.0 to 10.2 h. Both groups required supplementation with peripheral nerve blocks or general anesthesia in a large number of cases, with 9 of the 22 patients in the bupivacaine group and 8 of the 22 patients in the ropivacaine group requiring supplementation to allow surgery to begin. In view of the frequent need for supplementation noted with both 0.25% ropivacaine and 0.25% bupivacaine, we do not recommend using the 0.25% concentrations of these local anesthetics to provide brachial plexus block.

This article has been cited by other articles:

				J.-W. Yi, B.-J. Lee, D.-O. Kim, S.-W. Park, Y.-K. Choi, H.-K. Chang, C.-J. Kim, and J.-H. Park Effects of bupivacaine and ropivacaine on field potential in rat hippocampal slices Br. J. Anaesth., May 1, 2009; 102(5): 673 - 679. [Abstract] [Full Text] [PDF]

				P. Beaulieu, D. Babin, and T. Hemmerling The pharmacodynamics of ropivacaine and bupivacaine in combined sciatic and femoral nerve blocks for total knee arthroplasty. Anesth. Analg., September 1, 2006; 103(3): 768 - 774. [Abstract] [Full Text] [PDF]

				J. B. Whiteside and J. A. W. Wildsmith Developments in local anaesthetic drugs Br. J. Anaesth., July 1, 2001; 87(1): 27 - 35. [Abstract] [Full Text] [PDF]

				C. Connolly, D. M. Coventry, and J. A. W. Wildsmith Double-blind comparison of ropivacaine 7.5 mg ml-1 with bupivacaine 5 mg ml-1 for sciatic nerve block Br. J. Anaesth., May 1, 2001; 86(5): 674 - 677. [Abstract] [Full Text] [PDF]

				P. Marhofer, C. Oismuller, B. Faryniak, C. Sitzwohl, N. Mayer, and S. Kapral Three-in-One Blocks with Ropivacaine: Evaluation of Sensory Onset Time and Quality of Sensory Block Anesth. Analg., January 1, 2000; 90(1): 125 - 125. [Abstract] [Full Text] [PDF]

				A. Casati, G. Fanelli, V. Cedrati, M. Berti, G. Aldegheri, and G. Torri Pulmonary Function Changes After Interscalene Brachial Plexus Anesthesia with 0.5% and 0.75% Ropivacaine: A Double-Blinded Comparison with 2% Mepivacaine Anesth. Analg., March 1, 1999; 88(3): 587 - 587. [Abstract] [Full Text] [PDF]